Frontiers in Cell and Developmental Biology · 2021 · 84 citations · 43 references
Life SciencesCell BiologyCell TherapyRegenerative MedicineStem Cell BiologyMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyPluripotent Stem CellsSingle-cell Multi-omics IntegrationStem Cell DifferentiationTissue Engineering With Stem CellsExpansionHeterogeneityInduced Pluripotent Stem Cell TherapyMesenchymal Stem Cell ExpansionMesenchymal Stem Cell ProliferationMolecular CharacterizationPrecision Medicine ApplicationsScalable Production
Mesenchymal stem cells (MSC) isolated from different tissue sources exhibit multiple biological effects and have shown promising therapeutic effects in a broad range of diseases. In order to fulfill their clinical applications in context of precision medicine, however, more detailed molecular characterization of diverse subgroups and standardized scalable production of certain functional subgroups would be highly desired. Thus far, the generation of induced pluripotent stem cell (iPSC)-derived MSC (iMSC) seems to provide the unique opportunity to solve most obstacles that currently exist to prevent the broad application of MSC as an advanced medicinal product. The features of iMSC include their single cell clone origins, and defined and controllable cultural conditions for their derivation and proliferation. Still, comprehensive research of the molecular and functional heterogeneity of iMSC, just like MSC from any other tissue types, would be required. Furthered on previous efforts on iMSC differentiation and expansion platform and transcriptomic studies, advantages of single cell multi-omics analysis and other up-to-dated technologies would be taken in order to elucidate the molecular origin and regulation of heterogeneity and to obtain iMSC subgroups homogeneous enough for particular clinical conditions. In this perspective, the current obstacles in MSC applications, the advantages of iMSC over MSC and their implications for biological research and clinical applications will be discussed.
43
Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome
Maria Eriksson, W. Ted Brown, Leslie B. Gordon et al. · Nature · 2003 · 2.2K citations · Full text
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta, Sultan Abdul-Jawad, Laura E. McCoy et al. · Nature · 2019 · 592 citations · Full text